Brief: Kiromic Biopharma Says Daniel Clark Appointed As Interim Chief Financial Officer
06/10/2021 03:15
Oct 5 (Reuters) - Kiromic Biopharma Inc KRBP.O :
* KIROMIC BIOPHARMA ANNOUNCES CHIEF FINANCIAL OFFICER
TRANSITION
* KIROMIC BIOPHARMA INC - DANIEL CLARK APPOINTED AS INTERIM
CHIEF
FINANCIAL OFFICER
Source text for Eikon: ID:nBw8QywLGa
Further company coverage: KRBP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiromic Biopharma
See all newsBrief: Kiromic Biopharma Files For Offering Up To 1 Million Units
Brief: Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'
Brief: Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation
Brief: Kiromic Biopharma Reports Favorable Results At Six Weeks From Fourth Patient In Deltacel-01 Clinical Trial
Brief: Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site